About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Biocon Research to Get Investment from GE Capital

by Kathy Jones on November 2, 2012 at 8:24 PM
Font : A-A+

 Biocon Research to Get Investment from GE Capital

An official announcement confirmed that GE Capital will invest Rs.125 crore ($24 million) for a minority stake in the research arm of the country's biotech major Biocon Ltd.

"GE Capital's Mauritius subsidiary (GE Equity International) will invest Rs.125 crore for a 7.69 percent equity share in our research services subsidiary Syngene International Ltd.," Biocon chairperson Kiran Mazumdar Shaw told reporters here.

Advertisement

Noting that the private equity investment would propel Syngene to go public soon, Shaw said GE's decision validated the subsidiary's business model to deliver value to its partners and investors.

"The investment will enable us to expand Syngene's discovery and development services platform and harness the global outsourcing opportunity to foster strategic partnerships with leading pharma and biotech firms," the subsidiary's director Peter Bains said.
Advertisement

Syngene's contract research reported 15 percent year-on-year (YoY) growth in the first half (April-Sept) of this fiscal (2012-13) to Rs.734 crore from Rs.640 crore in the same period last fiscal (211-12), on strong performance of immuno-suppressants, insulins, Fidaxomicin and Orlistat.

Syngene posted sales turnover of Rs.250 crore during the six months of fiscal 2013 as against Rs.400 crore in the entire last fiscal (2011-12).

For second quarter (July-Sept), the research subsidiary registered 39 percent YoY growth to Rs.129 crore from Rs.93 crore a year ago.

"We seek to add value to companies we invest in, by sharing our expertise and experience in innovation, technology and global expansion," GE India chief executive John Flannery said in a statement here.

As a leading contract research organisation, Syngene offers integrated drug discover-and-development services with domain expertise in medicinal chemistry, in vivo pharmacology, toxicology, custom synthesis and formulation development for molecules.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
Are Menopause Symptoms Troubling You?: Try these Options
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Drug Side Effects Calculator Blood Donation - Recipients Sanatogen Drug - Food Interactions Color Blindness Calculator The Essence of Yoga Nutam (400mg) (Piracetam) Hearing Loss Calculator How to Reduce School Bag Weight - Simple Tips Diaphragmatic Hernia

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use